SEP 14, 2016 6:17 AM PDT

Scientists Uncover a Molecular Pac-Man that May Fight Cancer

WRITTEN BY: Xuan Pham
In researching how the breast clears out cells after the milk supply is finished, scientists at the University of Sheffield have inadvertently identified a protein that may help curb cancer growth. The protein of interest appears to gobble up nearby dead cells to prevent inflammation, kind of like a molecular Pac-Man.


 "It is thought that we shed the equivalent of our own body weight in dead cells every year," said Nasreen Ahktar, professor at the Sheffield’s Department of Oncology and Metabolism. But where do these cells go? How does the body get rid of them?
 
To answer this puzzle, Ahktar and his team focused on the breast, which is well known to undergo major changes before, during, and after lactation. In particular, when the job of producing milk is finished, the breast alveoli cells revert back to pre-pregnancy state. In studying this process, Ahktar and his team discovered a protein named Rac1.
 
Rac1 is apparently important for both stimulating the alveoli cells to secrete milk, but it is also vital in cell removal after the milk dries up. The Rac1 signal seems to tell cells to “eat” neighboring cells that are dead or dying. This clears up cellular debris and promotes renewal.
 
"By doing the job themselves, the breast epithelia limit both the numbers and time of immune phagocyte infiltration which protects the tissue from becoming damaged,” said Ahktar. "Without Rac1, the dead cells and milk flood the interconnecting breast ducts causing them to bloat and triggering chronic inflammation. The bloated ducts then fail to regenerate and produce milk in a future pregnancy."
 

While the results are significant in the field of developmental biology, Ahktar’s team is hopeful that this process can be applied to cancer biology. If in normal cells, Rac1 promotes cellular phagocytosis and reduce inflammation, how do cancer cells use (or abuse) Rac1? And more importantly, can scientists tame this protein and direct it against cancer? Answering these questions and more may provide a therapeutic target for curbing cancer’s growth.
 
But first, scientists have to contend with a contradiction. "Rac1 is over expressed in various cancers including breast cancer and Rac1 inhibitors are currently being considered as anticancer therapies,” said Ahktar. By contrast, Ahktar’s findings seem to suggest blocking Rac1 would be a bad idea.  
 
In particular, Ahktar said, "… in the breast, one of [Rac1’s] central roles is to prevent harmful inflammatory responses. Without Rac1 these responses are heightened and prolonged within tissues.”
 
The results underscore the need for further research into understanding the mechanism behind this molecular Pac-Man.
 
Additional source: The University of Sheffield
About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
APR 14, 2021
Clinical & Molecular DX
AI-Powered Imaging System Can Tell If a Patient Is Cancer-Free
APR 14, 2021
AI-Powered Imaging System Can Tell If a Patient Is Cancer-Free
A patient undergoes chemotherapy and radiation for rectal cancer. How do doctors know whether all the malignant tissue h ...
APR 05, 2021
Cancer
Introducing DeepTCR, the deep-learning software for T-cell receptor sequencing data
APR 05, 2021
Introducing DeepTCR, the deep-learning software for T-cell receptor sequencing data
A team from the Bloomberg~Kimmel Institute for Cancer Immunotherapy at the Johns Hopkins Kimmel Cancer Center is introdu ...
MAY 05, 2021
Immunology
Novel 3D Bio-printed Leukemia Model Shows Potential for Treatment Testing Platform
MAY 05, 2021
Novel 3D Bio-printed Leukemia Model Shows Potential for Treatment Testing Platform
Three-dimensional (3D) printing has become a common technique over the past two decades. Now, the technique has been ado ...
MAY 11, 2021
Immunology
Immune Cells Help Brain Tumors Spread, but We Can Stop Them
MAY 11, 2021
Immune Cells Help Brain Tumors Spread, but We Can Stop Them
Researchers have discovered how a glitch in the brain’s immune system can inadvertently cause an accelerated growt ...
JUN 08, 2021
Immunology
Fueling the Immune System's Killers
JUN 08, 2021
Fueling the Immune System's Killers
There’s a group of “killers” protecting your body against infections and eliminating potentially cance ...
JUN 11, 2021
Cell & Molecular Biology
Bad Fat in the Tumor Microenvironment May Disrupt Killer T Cells
JUN 11, 2021
Bad Fat in the Tumor Microenvironment May Disrupt Killer T Cells
The immune system can detect and destroy pathogenic and cancerous cells, but sometimes those dangerous cells can evade t ...
Loading Comments...